Main results of the Ouabain and Adducin for Specific Intervention on Sodium in Hypertension Trial (OASIS-HT): a randomized placebo-controlled phase-2 dose-finding study of rostafuroxin
Authors:
- Jan A StaessenJSJan A Staessen
- Lutgarde ThijsLTLutgarde Thijs
- Katarzyna Stolarz-SkrzypekKSKatarzyna Stolarz-Skrzypek
- Antonella BacchieriABAntonella Bacchieri
- John BartonJBJohn Barton
- Ezio degli EspositiEEEzio degli Espositi
- Peter W de LeeuwPLPeter W de Leeuw
- Mirosław DłużniewskiMDMirosław Dłużniewski
- Nicola GloriosoNGNicola Glorioso
- Andrzej JanuszewiczAJAndrzej Januszewicz
- Paolo ManuntaPaolo Manunta
- Viktor MilyaginVMViktor Milyagin
Open Access
- 14 January 2011
- journal article
- research article
- Published by Springer Nature in Trials
- Vol. 12 (1) , 13
Abstract
The Ouabain and Adducin for Specific Intervention on Sodium in Hypertension (OASIS-HT) Trial was a phase-2 dose-finding study of rostafuroxin, a digitoxygenin derivative, which selectively antagonizes the effects of endogenous ouabain (EO) on Na+,K+-ATPase and mutated adducin. Rostafuroxin lowered blood pressure (BP) in some animal models and in humans.Keywords
This publication has 19 references indexed in Scilit:
- Left ventricular geometry and endogenous ouabain in a Flemish populationJournal Of Hypertension, 2009
- Rostafuroxin: an ouabain antagonist that corrects renal and vascular Na+-K+- ATPase alterations in ouabain and adducin-dependent hypertensionAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2006
- OASIS-HT: Design of a Pharmacogenomic Dose-Finding StudyPharmacogenomics, 2005
- Epistatic interaction between α- and γ-adducin influences peripheral and central pulse pressures in white EuropeansJournal Of Hypertension, 2005
- The endogenous ouabain: molecular basis of its role in hypertension and cardiovascular complicationsFrontiers in Bioscience-Landmark, 2005
- Plasma Ouabain-Like Factor During Acute and Chronic Changes in Sodium Balance in Essential HypertensionHypertension, 2001
- PST 2238: A New Antihypertensive Compound that Modulates Na+,K+‐ATPase and Antagonizes the Pressor Effect of OLFCardiovascular Drug Reviews, 1999
- Prediction of the actual awake and asleep blood pressures by various methods of 24 h pressure analysisJournal Of Hypertension, 1996
- 208 Number of measurements required for analysis of the diurnal blood pressure curve in normal subjectsJournal Of Hypertension, 1993
- Accuracy of the SpaceLabs 90207 determined by the British Hypertension Society ProtocolJournal Of Hypertension, 1991